Marketocracy Masters 100 Fund (MOFQX)

10.44
Net Asset Value
+1.26%
1 Day
+4.19%
Year-to-Date
Overall Morningstar Rating
Mid-cap blend
Style or Category
No Load
Sales Expenses
2.04%
Expense Ratio
Average
Morningstar Risk Rating™
Investment Objective The investment seeks capital appreciation. The fund primarily invests in stocks of U.S. and foreign companies of any size, seeking to outperform the Standard & Poor's 500 Composite Stock Price Index ("S&P 500 Index"). The types of securities in which the fund will generally invest include common stocks, preferred stocks, American Depositary Receipts ("ADRs"), investment companies and exchange traded funds ("ETFs").

Performance

1 month-1.34% 3 years+2.42%
3 months+3.31% 5 years+4.81%
1 year-0.88% Since inception+3.73%
Data through --

Peer Comparisonvs. Mid-cap blend

 MOFQXCategory
Performance 5-yr return+4.81%+14.77%
Expense ratio2.04%1.22%
Risk 5 year sharpe ratio0.420.98
Net assets$6.4M$1.7B
Average market cap$2.2B$8.2B
Average P/E18.320.0
Portfolio turnover566%566%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyMarketocracy Funds
Fund manager & tenureKendrick Kam / 17 Years
Minimal initial investment$10,000.00
Minimum IRA investment--

Holdings

U.S. stock72.16%
Cash15.16%
International stock12.27%
Fixed income0.40%
Other0.01%
Top 5 Sectors
Portfolio weighting
Healthcare 30.41%
Industrial materials 14.05%
Energy 11.81%
Financial service 11.55%
Hardware 8.17%
Top 10 Holdings
Portfolio weighting
AAL American Airlines8.62%
HALO Halozyme Therapeutics Inc3.66%
-- 2.40%
BLUE bluebird bio Inc2.36%
ALJ Alon USA Energy Inc2.01%
NVAX Novavax Inc1.96%
PACB Pacific Biosciences of California Inc1.71%
RNF Rentech Nitrogen Partners LP1.49%
MNK Mallinckrodt Plc1.49%
KERX Keryx Biopharmaceuticals Inc1.46%

To view my watchlist

Not a member yet?

Sign up now for a free account